Yhn BusinessStartups first seen 1 d ago, last 42 min ago, peak #4
Open-source Covid-19 vaccine PVX-001 enters Phase 1 trial
Original: PVX-001: open-source Covid-19 vaccine starts Phase 1 trial
PopVax's open-source Covid-19 vaccine candidate, PVX-001, has begun its first Phase 1 clinical trial. The development is drawing attention because the vaccine is being developed openly, an unusual approach in an industry dominated by proprietary drug development. Supporters of open-source medicine see the trial as a test of whether transparent, freely shared vaccine research can produce a viable clinical product.
Why now: The start of the first human trial of an openly developed vaccine is a notable milestone for the open-source medicine movement.
Evidence
- PVX-001: open-source Covid-19 vaccine starts Phase 1 trial · jajoosam · 139
API: https://socialmediatrends-api.osmike.com/v1/trends/1751596